“…Yet, a recurrence rate of 14.7% to 60% (1-4) and a rebleeding rate of 13.2% to 55.3% (2, 5-10) with sclerotherapy have been reported, not differing much from the early reports on sclerotherapy, in spite of significant recent improvement in instruments and materials (22,23). At the inception of sclerotherapy, splenectomy had been tried during or after the treatment for esophageal varices to reduce the recurrence rate (24,25). MacBeth had evaluated a combined ther- apy of splenectomy and sclerotherapy for esophageal varices because the splenectomy blocked the variceal blood supply route and, at the same time, caused a significant decrease in portal blood flow (25).…”